Loading insider details...
Beta
Latest Form 4 (May 20, 2026): Grant/Award of 5,750 RIGL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 20, 2026 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 5,750 | n/a |
| Jan 9, 2026 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 50,000 | n/a |
| Jun 2, 2025 | SELLAS Life Sciences Group, Inc. (SLS) | Purchase | 20,000 | $33.8K |
| May 28, 2025 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 2,500 | n/a |
| Jan 14, 2025 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 12,500 | n/a |
| May 29, 2024 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 25,000 | n/a |
| Jan 25, 2024 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 6,000 | n/a |
| Jul 12, 2023 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 25,000 | n/a |
| Feb 3, 2023 | SELLAS Life Sciences Group, Inc. (SLS) | Grant/Award | 2,500 | n/a |
| May 23, 2022 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/Award | 25,000 | n/a |